In part 2, Christine Pfaff, RPh, MBA, explores reimbursement gaps, new payment models, and payer partnerships needed to expand cellular therapy access.

Employers need a voice at the table with health systems, hospitals, and carriers in shaping cancer care, according to Rosa ...

Home phototherapy occupies an unusual position in the psoriasis treatment landscape: an option with randomized evidence of ...

Technology, particularly artificial intelligence (AI), represents the biggest structural shift in oncology drug development over the past 5 years, according to David Spigel, MD, p ...

Baricitinib is now FDA approved for adolescents 12 and older with severe alopecia areata, extending the once-daily pill ...